AAP
VHT icon

Arax Advisory Partners’s Vanguard Health Care ETF VHT Stock Holding History

Arax Advisory Partners’s Portfolio VHT Stock Details VHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.92M Buy
23,144
+14,368
+164% +$3.99M 0.05% 391
2026
Q1 		$2.39M Buy
8,776
+2,239
+34% +$640K 0.07% 236
2025
Q4 		$1.88M Buy
+6,537
New +$1.83M 0.05% 247
2025
Q3 		– Sell
-7,145
Closed -$1.77M – 4294
2025
Q2 		$1.77M Buy
7,145
+784
+12% +$194K 0.08% 161
2025
Q1 		$1.68M Sell
6,361
-1,671
-21% -$445K 0.11% 123
2024
Q4 		$2.04M Sell
8,032
-81
-1% -$21.8K 0.13% 107
2024
Q3 		$2.29M Sell
8,113
-498
-6% -$138K 0.2% 64
2024
Q2 		$2.29M Sell
8,611
-602
-7% -$158K 0.22% 63
2024
Q1 		$2.49M Sell
9,213
-74
-0.8% -$19.4K 0.26% 55
2023
Q4 		$2.33M Buy
9,287
+747
+9% +$177K 0.26% 57
2023
Q3 		$2.01M Buy
8,540
+580
+7% +$141K 0.25% 61
2023
Q2 		$1.95M Buy
7,960
+812
+11% +$198K 0.25% 53
2023
Q1 		$1.7M Buy
7,148
+201
+3% +$48.4K 0.23% 51
2022
Q4 		$1.72M Sell
6,947
-1,306
-16% -$317K 0.24% 52
2022
Q3 		$1.85M Buy
8,253
+478
+6% +$114K 0.29% 45
2022
Q2 		$1.83M Sell
7,775
-23
-0.3% -$5.54K 0.28% 49
2022
Q1 		$1.98M Sell
7,798
-272
-3% -$67.2K 0.26% 49
2021
Q4 		$2.15M Buy
8,070
+537
+7% +$137K 0.27% 50
2021
Q3 		$1.86M Sell
7,533
-159
-2% -$40.8K 0.25% 51
2021
Q2 		$1.9M Buy
+7,692
New +$1.84M 0.26% 52
2020
Q4 		$1.52M Sell
6,800
-662
-9% -$142K 0.23% 48
2020
Q3 		$1.52M Buy
7,462
+1
+0% +$202 0.26% 48
2020
Q2 		$1.44M Sell
7,461
-124
-2% -$23.3K 0.26% 49
2020
Q1 		$1.26M Buy
7,585
+7,182
+1,782% +$1.31M 0.29% 45
2019
Q4 		$77K Sell
403
-98
-20% -$17.6K 0.02% 282
2019
Q3 		$84K Sell
501
-100
-17% -$17.1K 0.03% 262
2019
Q2 		$105K Buy
+601
New +$101K 0.04% 228
2018
Q4 		$123K Buy
766
+1
+0.1% +$169 0.05% 162
2018
Q3 		$138K Buy
+765
New +$132K 0.06% 158

Other funds holding VHT

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PCH
PGIM Custom Harvest Newark, New Jersey $7.98B AUM 28.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Arax Advisory Partners's VHT Position: Q2 2026 in Review

Arax Advisory Partners increased its Vanguard Health Care ETF (VHT) stake by 164% in Q2 2026, buying an estimated $3.99M and bringing the position to 23,144 shares worth $6.92M. The position accounts for 0.05% of the portfolio, ranked #391.

Arax Advisory Partners first reported a position in VHT in Q3 2018 and has held it in 29 quarters since. 1,112 funds tracked by Wall St. Rank hold VHT as of Q2 2026.

  • Arax Advisory Partners held 23,144 shares of Vanguard Health Care ETF worth $6.92M as of Q2 2026.
  • Arax Advisory Partners bought 14,368 Vanguard Health Care ETF shares in Q2 2026, an estimated $3.99M.
  • Vanguard Health Care ETF made up 0.05% of Arax Advisory Partners's portfolio in Q2 2026, its #391 holding.
  • Arax Advisory Partners first reported a position in Vanguard Health Care ETF in Q3 2018 and has held it in 29 quarters since.
  • 1,112 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.